Acrux Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARUXF research report →
Price Chart
About the company
Acrux Limited, alongside its affiliated entities, specializes in the global development and commercialization of generic and topical pharmaceutical products. The company's reach extends across international markets, including Australia, Europe, and the United States. A significant part of its offerings includes diverse testosterone therapies, available in various forms such as oral and buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels, all aimed at treating adult men with low or absent testosterone levels.
- CEO
- John Warmbrunn
- IPO
- 2010
- Employees
- 43
- HQ
- West Melbourne, VIC, AU
Get TickerSpark's AI analysis on ARUXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.32M
- P/E
- -7.86
- Fwd P/E
- 0.27
- PEG
- -0.04
- P/S
- 1.40
- P/B
- 3.15
- EV/EBITDA
- -4.29
- Div Yield
- 0.00%
- Gross Margin
- 90.57%
- Op Margin
- -46.06%
- Net Margin
- -13.01%
- ROE
- -45.29%
- ROIC
- -10.70%
Latest fiscal year · YoY change
- Revenue
- $4.64M+289.7%
- Gross Profit
- $4.20M+253.0%
- Op Income
- $-2,136,000
- Net Income
- $-603,153+89.9%
- EPS
- $-0.00+91.7%
- OCF Growth
- +118.6%
- FCF Growth
- +118.6%
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.97
- RSI (14)
- 1
- Avg Volume
- 641
No earnings-call transcripts are available for ARUXF yet.
- Free Float
- 76.8%
- Shares Outstanding
- 401.43M
- Float Shares
- 308.37M
Our ARUXF coverage
Recent articles, reports, and earnings notes.
No research on ARUXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARUXF report →